Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LTA4H | P09960 | 3/20 | 0.41 |
| ▸ | TSHR | P16473 | 2/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.38 |
| ▸ | CA4 | P22748 | 1/20 | 0.38 |
| ▸ | KCNA3 | P22001 | 1/20 | 0.35 |
| ▸ | CCR6 | P51684 | 1/20 | 0.34 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.34 |
| ▸ | MLYCD | O95822 | 1/20 | 0.33 |
| ▸ | CA5A | P35218 | 1/20 | 0.33 |
| ▸ | CA5B | Q9Y2D0 | 1/20 | 0.33 |
| ▸ | KIF11 | P52732 | 1/20 | 0.33 |
| ▸ | POLB | P06746 | 1/20 | 0.33 |
| ▸ | PDK1 | Q15118 | 1/20 | 0.33 |
| ▸ | PDK2 | Q15119 | 1/20 | 0.33 |
| ▸ | PDK3 | Q15120 | 1/20 | 0.33 |
| ▸ | PDK4 | Q16654 | 1/20 | 0.33 |
| ▸ | GRIN2B | Q13224 | 1/20 | 0.33 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.32 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.32 |
| ▸ | RAB9A | P51151 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24615573 | 0.79 | LTA4H (0.41) | LTA4HTSHRALDH1A1CA4KCNA3 | |
| SCHEMBL10604957 | 0.79 | TSHR (0.41) | LTA4HTSHRALDH1A1CA4KCNA3 | |
| SCHEMBL6000951 | 0.79 | LTA4H (0.41) | LTA4HTSHRALDH1A1CA4KCNA3 | |
| SCHEMBL168125 | 0.78 | KIF11 (0.47) | LTA4HTSHRCCR6KCNH2KIF11 | |
| SCHEMBL19747191 | 0.77 | LMNA (0.31) | CA4CCR6KCNH2 | |
| SCHEMBL29087324 | 0.76 | KIF11 (0.46) | LTA4HTSHRCCR6KCNH2KIF11 | |
| Fluoride SCHEMBL28371495 | 0.76 | KIF11 (0.46) | LTA4HTSHRCCR6KCNH2KIF11 | |
| SCHEMBL4036809 | 0.76 | KIF11 (0.46) | LTA4HTSHRCCR6KCNH2KIF11 | |
| Ammonia Solution, Strong SCHEMBL2163079 | 0.76 | KIF11 (0.46) | LTA4HTSHRCCR6KCNH2KIF11 | |
| SCHEMBL9326176 | 0.76 | LTA4H (0.43) | LTA4HTSHRALDH1A1CA4KCNA3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 241 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0543950-B1 | FLUORINATED QUINOLINE POLYMERS AND THE CORRESPONDING FLUORINATED MONOMERS | HITACHI CHEMICAL CO LTD (JP) | 1998-06-24 | — | — | EP | claimed |
| EP-0543950-A4 | FLUORINATED QUINOLINE POLYMERS AND THE CORRESPONDING FLUORINATED MONOMERS | — | 1993-10-27 | — | — | EP | claimed |
| EP-0543950-A1 | FLUORINATED QUINOLINE POLYMERS AND THE CORRESPONDING FLUORINATED MONOMERS | HITACHI CHEMICAL CO., LTD. (JP) | 1993-06-02 | — | — | EP | claimed |
| EP-4097180-A1 | HYDROPHOBIC COATING COMPOSITIONS | Momentive Performance Materials Inc. (US) | 2022-12-07 | — | — | EP | disclosed |
| EP-3902861-A1 | CURABLE SILICONE-BASED COMPOSITIONS AND APPLICATIONS THEREOF | Momentive Performance Materials Inc. (US) | 2021-11-03 | — | — | EP | disclosed |
| WO-2021154504-A1 | HYDROPHOBIC COATING COMPOSITIONS | MOMENTIVE PERFORMANCE MATERIALS INC. (US) | 2021-08-05 | — | — | WO | disclosed |
| EP-3794056-A1 | ZWITTERION-FUNCTIONALIZED MULTICOMPONENT COPOLYMERS AND ASSOCIATED POLYMER BLENDS AND MEMBRANES | Cytiva Sweden AB (SE) | 2021-03-24 | — | — | EP | disclosed |
| WO-2020139642-A1 | CURABLE SILICONE-BASED COMPOSITIONS AND APPLICATIONS THEREOF | MOMENTIVE PERFORMANCE MATERIALS INC. (US) | 2020-07-02 | — | — | WO | disclosed |
| EP-3320542-A1 | INSULATED WINDINGS AND METHODS OF MAKING THEREOF | General Electric Company (US) | 2018-05-16 | — | — | EP | disclosed |
| WO-2017176966-A1 | SELF-COOLING ELECTRIC SUBMERSIBLE PUMP | GENERAL ELECTRIC COMPANY (US) | 2017-10-12 | — | — | WO | disclosed |
| EP-3221036-A1 | ZWITTERION-FUNCTIONALIZED COPOLYMER HOLLOW-FIBER MEMBRANES AND ASSOCIATED METHOD | General Electric Company (US) | 2017-09-27 | — | — | EP | disclosed |
| US-20060074202-A1 | Stabilized polycarbonate polyester composition | GENERAL ELECTRIC COMPANY | 2006-04-06 | — | — | US | disclosed |
| US-20060074155-A1 | Halogen-free flame retardant polyester | GENERAL ELECTRIC COMPANY | 2006-04-06 | — | — | US | disclosed |
| US-20060069236-A1 | Polyethersulfone compositions with high heat and good impact resistance | GENERAL ELECTRIC COMPANY | 2006-03-30 | — | — | US | disclosed |
| US-20060069222-A1 | Curable formulations, cured compositions, and articles derived thereform | GENERAL ELECTRIC COMPANY | 2006-03-30 | — | — | US | disclosed |
| US-20060066004-A1 | Method for controlling haze in an article comprising a polymer composition | GENERAL ELECTRIC COMPANY | 2006-03-30 | — | — | US | disclosed |
| US-20060069291-A1 | Phosphazenium salt phase transfer catalysts | GENERAL ELECTRIC COMPANY | 2006-03-30 | — | — | US | disclosed |
| EP-1640403-A2 | Polyethersulfone compositions with high heat and good impact resistance | GENERAL ELECTRIC COMPANY (US) | 2006-03-29 | — | — | EP | disclosed |
| EP-1640067-A2 | Phosphazenium salt phase transfer catalysts | GENERAL ELECTRIC COMPANY (US) | 2006-03-29 | — | — | EP | disclosed |
| WO-2005073271-A1 | COMPOSITIONS USEFUL AS COATINGS, THEIR PREPARATION, AND ARTICLES MADE THEREFROM | GENERAL ELECTRIC COMPANY (US) | 2005-08-11 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060069291-A1 | Phosphazenium salt phase transfer catalysts | PHOSPHO1, MPST, PAPSS1 | LTA4H 3728/4885TSHR 3940/4885ALDH1A1 4713/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.